PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 149 filers reported holding PROMETHEUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.60 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $769,000 | – | 13,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 1,848,024 | $69,781,000 | 76.33% |
| CHI Advisors LLC | 1,585,096 | $59,853,000 | 25.45% |
| Cormorant Asset Management, LP | 1,823,444 | $68,853,000 | 5.29% |
| Waypoint Capital Advisors, LLC | 235,756 | $8,725,000 | 5.13% |
| Boxer Capital, LLC | 1,714,000 | $64,721,000 | 3.33% |
| Decheng Capital Management III (Cayman), LLC | 250,000 | $9,440,000 | 2.89% |
| Tri Locum Partners LP | 149,066 | $5,629,000 | 2.20% |
| RTW INVESTMENTS, LP | 2,757,947 | $104,140,000 | 2.16% |
| Eventide Asset Management | 3,232,700 | $122,067,000 | 1.91% |
| Perceptive Advisors | 2,440,582 | $92,156,000 | 1.85% |